Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 31, 2025
Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironmentBárbara Carreira, Rita C Acúrcio, Ana I Matos, et al.Nature Nanotechnology|August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulatorsJoão Conniot, Anna Scomparin, Carina Peres, et al.Journal for Immunotherapy of Cancer|July 21, 2022
Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironmentRita C Acúrcio, Sabina Pozzi, Barbara Carreira, et al.Cell Discovery|June 4, 2024
Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissueSaumya Kumar, Afonso P Basto, Filipa Ribeiro, et al.Science Advances|December 13, 2024
Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancersShani Koshrovski-Michael, Daniel Rodriguez Ajamil, Pradip Dey, et al.JCI Insight|August 18, 2022
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progressionSabina Pozzi, Anna Scomparin, Dikla Ben-Shushan, et al.Advanced Materials (Deerfield Beach, Fla.)|February 12, 2025
Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against MelanomaLiane If Moura, Alessio Malfanti, Ana I Matos, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 8, 2024
Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 ImmunotherapyRita C Acúrcio, Ron Kleiner, Daniella Vaskovich-Koubi, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 11, 2023
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid TumorsAna I Matos, Carina Peres, Barbara Carreira, et al.Advanced Functional Materials|November 5, 2025
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint TherapyCarina Peres, Ana I Matos, Bárbara Carreira, et al.Pageof 5